666

CRYOFOCUS MEDTECH SHANGHAI CO LTD

No trades
See on Supercharts
Market capitalization
‪3.11 B‬HKD
−0.45HKD
‪−107.72 M‬HKD
‪45.25 M‬HKD
‪27.83 M‬
Beta (1Y)
1.01

About CRYOFOCUS MEDTECH SHANGHAI CO LTD

CEO
Jun Zhu
Headquarters
Shanghai
Employees (FY)
392
Founded
2013
ISIN
CNE100005MV5
FIGI
BBG01C1KH3Y4
Cryofocus Medtech (Shanghai) Co. Ltd. medical device company, which manufactures cryoablation devices. Its products are bladder cyoablation system and the endoscopic clip for anastomosis. The company was founded on March 15, 2013 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 6922 is 7.99 HKD — it has increased by 2.44% in the past 24 hours. Watch CRYOFOCUS MEDTECH SHANGHAI CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CRYOFOCUS MEDTECH SHANGHAI CO LTD stocks are traded under the ticker 6922.
6922 stock is 3.81% volatile and has beta coefficient of 1.01. Track CRYOFOCUS MEDTECH SHANGHAI CO LTD stock price on the chart and check out the list of the most volatile stocks — is CRYOFOCUS MEDTECH SHANGHAI CO LTD there?
Yes, you can track CRYOFOCUS MEDTECH SHANGHAI CO LTD financials in yearly and quarterly reports right on TradingView.
6922 stock has fallen by 36.49% compared to the previous week, the month change is a 35.87% fall, over the last year CRYOFOCUS MEDTECH SHANGHAI CO LTD has showed a 56.53% decrease.
6922 net income for the last quarter is ‪−58.43 M‬ HKD, while the quarter before that showed ‪−49.09 M‬ HKD of net income which accounts for −19.03% change. Track more CRYOFOCUS MEDTECH SHANGHAI CO LTD financial stats to get the full picture.
No, 6922 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6922 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CRYOFOCUS MEDTECH SHANGHAI CO LTD stock right from TradingView charts — choose your broker and connect to your account.
6922 reached its all-time high on Oct 3, 2023 with the price of 19.50 HKD, and its all-time low was 6.00 HKD and was reached on Jan 18, 2024. View more price dynamics on 6922 chart.
See other stocks reaching their highest and lowest prices.
As of May 9, 2024, the company has 392.00 employees. See our rating of the largest employees — is CRYOFOCUS MEDTECH SHANGHAI CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CRYOFOCUS MEDTECH SHANGHAI CO LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CRYOFOCUS MEDTECH SHANGHAI CO LTD stock shows the strong sell signal. See more of CRYOFOCUS MEDTECH SHANGHAI CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CRYOFOCUS MEDTECH SHANGHAI CO LTD EBITDA is ‪−121.72 M‬ HKD, and current EBITDA margin is −269.46%. See more stats in CRYOFOCUS MEDTECH SHANGHAI CO LTD financial statements.